Dyslipidemia is the major constituent of MetS, characterized by raised free fatty acids (FFAs), TG, small dense low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) levels, but low HDL cholesterol level [2]. This evidence concerns the gene APOB and metabolic syndrome.